Topoisomerase
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
|
WikiDoc Resources for Topoisomerase | |
|
Articles | |
|---|---|
|
Most recent articles on Topoisomerase Most cited articles on Topoisomerase | |
|
Media | |
|
Powerpoint slides on Topoisomerase | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Topoisomerase at Clinical Trials.gov Trial results on Topoisomerase Clinical Trials on Topoisomerase at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Topoisomerase NICE Guidance on Topoisomerase
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Topoisomerase Discussion groups on Topoisomerase Patient Handouts on Topoisomerase Directions to Hospitals Treating Topoisomerase Risk calculators and risk factors for Topoisomerase
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Topoisomerase | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Topoisomerases (type I: EC 5.99.1.2, type II: EC 5.99.1.3) are isomerase enzymes that acts on the topology of DNA. It was first discovered by Harvard Professor James C. Wang.[1]
Function
The double-helical configuration that DNA strands naturally reside in makes them difficult to separate, and yet they must be separated by helicase proteins if other enzymes are to transcribe the sequences that encode proteins, or if chromosomes are to be replicated. In so-called circular DNA, in which double helical DNA is bent around and joined in a circle, the two strands are topologically linked, or knotted. Otherwise identical loops of DNA having different numbers of twists are topoisomers, and cannot be interconverted by any process that does not involve the breaking of DNA strands. Topoisomerases catalyze and guide the unknotting of DNA.
The insertion of viral DNA into chromosomes and other forms of recombination can also require the action of topoisomerases.
Clinical significance
- See also topoisomerase inhibitor
Many drugs operate through interference with the topoisomerases. The broad-spectrum fluoroquinolone antibiotics act by disrupting the function of bacterial type II topoisomerases.
Some chemotherapy drugs work by interfering with topoisomerases in cancer cells:
- type 1 is inhibited by irinotecan and topotecan.
- type 2 is inhibited by etoposide and teniposide.
Topoisomerase I is the antigen recognized by Anti Scl-70 antibodies in scleroderma.
Topological problems
There are three main types of topology; supercoiling, knotting and catenation. When outside of replication or transcription DNA needs to be kept as compact as possible and these three states help this cause. However when transcription or replication occur DNA needs to be free and these states seriously hinder the processes.
Types
Topoisomerases can fix these topological problems and are separated into two types separated by the number of strands cut in one round of action:
- Type I topoisomerase cuts one strand, passes the other through it then reanneals the cut strand.
- Type II topoisomerase cuts both strands, and passes an unbroken double strand through it then reanneals the cut strand.
Both type I and type II topoisomerases change the linking number of DNA.
References
- Champoux JJ (2001) DNA Topoisomerases: Structure, Function, and Mechanism Annual Review of Biochemistry 70: 369-413[2]
See also
External links
Proteins: enzymes | |
|---|---|
| Topics | Active site - Allosteric regulation - Binding site - Catalytically perfect enzyme - Coenzyme - Cofactor - Cooperativity - EC number Enzyme catalysis - Enzyme inhibitor - Enzyme kinetics - Lineweaver-Burk plot - Michaelis-Menten kinetics - List of enzymes |
| Types | EC1 Oxidoreductases/list - EC2 Transferases/list - EC3 Hydrolases/list - EC4 Lyases/list - EC5 Isomerases/list - EC6 Ligases/list |
Isomerase: topoisomerases (EC 5.99) |
|---|
| Type I topoisomerase - Type II topoisomerase (gyrase, topoisomerase IV) |
DNA replication |
|---|
| Origin of replication/Ori/Replicon - DNA clamp - Okazaki fragment - Replication fork (Lagging and leading strands) - Single-strand binding protein - Primer - Processivity - Klenow fragment |
| Pre-replication complex: Helicase (dnaA, dnaB, T7) - Primase (dnaG) - DNA polymerase III holoenzyme (dnaQ) |
| DNA ligase - Telomerase - Topoisomerase |
de:Topoisomerasefr:Topoisomérase it:Topoisomerasi ja:DNAトポイソメラーゼsv:Topoisomeras uk:Топоізомераза
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

